MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL), 5 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-473-01
Recall Number: D-1064-2022
Firm: Mckesson Medical-Surgical Inc. Corporate Office
Classification: Class II
Status: Terminated
Report Date: 20220615
Initiation Date: 20220413
Termination Date: 20231130
Reason for Recall
cGMP deviations: Temperature abuse
Product Description
MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL), 5 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-473-01